Nano-X Imaging logo

Nano-X Imaging

Stock
Stock
ISIN: IL0011681371
Ticker: NNOX
IL0011681371
NNOX

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Nano-X Imaging is $24.03M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Nano-X Imaging's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.709. EPS indicates the company's profitability on a per-share basis.
Currently, 3 analysts cover Nano-X Imaging's stock, with a consensus target price of $4.133. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Nano-X Imaging reported a revenue of $15.63M.
Nano-X Imaging's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$49.11M. EBITDA measures the company's overall financial performance.
Nano-X Imaging has a free cash flow of -$55.46M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Nano-X Imaging employs approximately 197 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Nano-X Imaging is 72.79M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$24.03M
EPS (TTM) 
-$1.709
Free Float 
72.79M
Revenue (TTM) 
$15.63M
EBITDA (TTM) 
-$49.11M
Free Cashflow (TTM) 
-$55.46M

Pricing

52W span
$0.279$4.705

Analyst Ratings

The price target is $4.133 and the stock is covered by 3 analysts.

Buy

2

Hold

1

Sell

0

Information

Nano-X Imaging Ltd. engages in the development of medical imaging systems. It operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Petach Tikva, Israel.

Employees
197
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
IL0011681371
Primary Ticker
NNOX
Fundamentals & EOD data from FactSet
Join the conversation